Recently, Diagreat was invited to participate in the 22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology held in Canada, to join hands with the international academic elites and to show the elegance of China's medical science and technology field!
This year's conference gathered experts and scholars in the field of therapeutic drug monitoring and clinical toxicology from all over the world, and Diagreat is honored to present our advantageous product - fully automated chemiluminescence solution for therapeutic drug concentration monitoring on this international stage.
With its high efficiency, precision and convenience, the solution attracted the attention of many guests during the exhibition. Diagreat is committed to providing high quality products and services to global healthcare organizations and helping the cause of precision medicine by driving development with innovation.
本
Diagreat's appearance at this international academic conference not only demonstrates the strength of China's biotechnology enterprises, but also contributes Chinese wisdom to the global healthcare industry. We will continue to uphold the concept of “Innovation, Quality, Service” and contribute to the development of global therapeutic drug monitoring.
